• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝硬化门静脉高压症合并脾功能亢进患者的抗体和补体水平及治疗原则

Antibody and complement levels in patients with hypersplenism associated with cirrhotic portal hypertension and therapeutic principles.

作者信息

Zhang Kun, Zeng Min, Li Ye-Juan, Wu Hong-Fei, Wu Jin-Cai, Zhang Zhen-Sheng, Zheng Jin-Fang, Lv Yun-Fu

机构信息

Department of Geriatric Center, Hainan General Hospital, Haikou 570311, Hainan Province, China.

Reproductive Medicine Center, Maternal and Child Health Care Hospital of Hainan Province, Haikou 570311, Hainan Province, China.

出版信息

World J Clin Cases. 2022 Dec 26;10(36):13208-13215. doi: 10.12998/wjcc.v10.i36.13208.

DOI:10.12998/wjcc.v10.i36.13208
PMID:36683645
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9850989/
Abstract

BACKGROUND

Hypersplenism associated with cirrhotic portal hypertension is a common condition often resulting from hepatitis B-related cirrhosis. However, the levels of immunoglobulin (Ig) and complement in patients with hypersplenism associated with cirrhotic portal hypertension remain unclear. This study was undertaken to determine the levels of Ig and complement in these patients, the relationship between these levels and Child-Pugh class and their clinical significance.

AIM

To investigate the antibody (Ig) and complement levels in patients with hypersplenism associated with cirrhotic portal hypertension and their clinical significance.

METHODS

Clinical data of 119 patients with hypersplenism associated with cirrhotic portal hypertension were statistically analyzed and compared with those of 128 control patients.

RESULTS

IgA and IgG levels in patients with hypersplenism were significantly higher than controls ( < 0.001). There was no significant difference in IgM between the two groups ( = 0.109). C3 and C4 levels in patients with hypersplenism were significantly lower than controls ( < 0.001). As liver function decreased, IgA and IgG levels increased ( < 0.001), and C3 and C4 levels decreased ( < 0.001).

CONCLUSION

Patients with hypersplenism associated with cirrhotic portal hypertension have significantly higher antibody (IgA and IgG) levels and significantly lower complement (C3 and C4) levels, which are both related to liver damage. Clinically, the administration of anti-hepatitis virus agents and protection of liver function should be strengthened.

摘要

背景

与肝硬化门静脉高压相关的脾功能亢进是一种常见病症,常由乙型肝炎相关肝硬化引起。然而,与肝硬化门静脉高压相关的脾功能亢进患者的免疫球蛋白(Ig)和补体水平仍不清楚。本研究旨在确定这些患者的Ig和补体水平、这些水平与Child-Pugh分级之间的关系及其临床意义。

目的

探讨与肝硬化门静脉高压相关的脾功能亢进患者的抗体(Ig)和补体水平及其临床意义。

方法

对119例与肝硬化门静脉高压相关的脾功能亢进患者的临床资料进行统计分析,并与128例对照患者的资料进行比较。

结果

脾功能亢进患者的IgA和IgG水平显著高于对照组(<0.001)。两组间IgM无显著差异(=0.109)。脾功能亢进患者的C3和C4水平显著低于对照组(<0.001)。随着肝功能下降,IgA和IgG水平升高(<0.001),C3和C4水平下降(<0.001)。

结论

与肝硬化门静脉高压相关的脾功能亢进患者的抗体(IgA和IgG)水平显著升高,补体(C3和C4)水平显著降低,两者均与肝损伤有关。临床上,应加强抗肝炎病毒药物的应用和肝功能的保护。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab2/9850989/906b27ffdf15/WJCC-10-13208-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab2/9850989/8db35074caf3/WJCC-10-13208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab2/9850989/8ac55c864635/WJCC-10-13208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab2/9850989/906b27ffdf15/WJCC-10-13208-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab2/9850989/8db35074caf3/WJCC-10-13208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab2/9850989/8ac55c864635/WJCC-10-13208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0ab2/9850989/906b27ffdf15/WJCC-10-13208-g003.jpg

相似文献

1
Antibody and complement levels in patients with hypersplenism associated with cirrhotic portal hypertension and therapeutic principles.肝硬化门静脉高压症合并脾功能亢进患者的抗体和补体水平及治疗原则
World J Clin Cases. 2022 Dec 26;10(36):13208-13215. doi: 10.12998/wjcc.v10.i36.13208.
2
Correlations of portal hypertensive gastropathy of hepatitis B cirrhosis with other factors.乙型肝炎肝硬化门静脉高压性胃病与其他因素的相关性。
Hepatobiliary Pancreat Dis Int. 2002 Nov;1(4):527-31.
3
Effect of surgery treatment on hypersplenism caused by cirrhotic portal hypertension.手术治疗对肝硬化门静脉高压症所致脾功能亢进的影响。
Minerva Chir. 2013 Aug;68(4):409-13.
4
Effect of antiviral therapy on the survival and incidence of major complications in HBV-associated cirrhotic patients after splenectomy for hypersplenism and portal hypertension.抗病毒治疗对脾功能亢进和门静脉高压症行脾切除术后乙型肝炎病毒相关肝硬化患者的生存和主要并发症发生率的影响。
Virol J. 2012 Nov 16;9:273. doi: 10.1186/1743-422X-9-273.
5
Indocyanine green retention is a potential prognostic indicator after splenectomy and pericardial devascularization for cirrhotic patients.对于肝硬化患者,脾切除及心包去血管化术后,吲哚菁绿滞留是一项潜在的预后指标。
Hepatobiliary Pancreat Dis Int. 2016 Aug;15(4):386-90. doi: 10.1016/s1499-3872(16)60114-5.
6
[Quantitative assessment of hepatic and splenic blood flow status in patients with hypersplenism of different degrees based on multi-slice spiral CT whole-liver perfusion imaging].基于多层螺旋CT全肝灌注成像对不同程度脾功能亢进患者肝脾血流状态的定量评估
Zhonghua Gan Zang Bing Za Zhi. 2020 Apr 20;28(4):326-331. doi: 10.3760/cma.j.cn501113-20190518-00174.
7
Risk Factors for Portal Vein System Thrombosis After Laparoscopic Splenectomy in Cirrhotic Patients with Hypersplenism.肝硬化脾功能亢进患者腹腔镜脾切除术后门静脉系统血栓形成的危险因素
J Laparoendosc Adv Surg Tech A. 2016 Jun;26(6):419-23. doi: 10.1089/lap.2015.0481. Epub 2016 Mar 8.
8
Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.慢性肝炎患者肝脏中的免疫球蛋白和补体沉积。
Hepatogastroenterology. 2008 May-Jun;55(84):1066-70.
9
Management of hypersplenism in non-cirrhotic portal hypertension: a surgical series.非肝硬化性门静脉高压症高脾血症的治疗:外科系列。
Hepatobiliary Pancreat Dis Int. 2012 Apr;11(2):165-71. doi: 10.1016/s1499-3872(12)60143-x.
10
A novel canine model of portal vein stenosis plus thioacetamide administration-induced cirrhotic portal hypertension with hypersplenism.一种新的犬门静脉狭窄加硫代乙酰胺给药诱导肝硬化门静脉高压伴脾功能亢进的模型。
Cell Biochem Biophys. 2012 Jan;62(1):245-55. doi: 10.1007/s12013-011-9272-7.

引用本文的文献

1
Thyroid hormone, immunoglobin and complements for predicting hepatocellular carcinoma development in patients with hepatitis B virus-related liver cirrhosis.甲状腺激素、免疫球蛋白及补体对预测乙型肝炎病毒相关性肝硬化患者肝细胞癌发生的作用
World J Hepatol. 2025 Feb 27;17(2):99092. doi: 10.4254/wjh.v17.i2.99092.

本文引用的文献

1
Impact of total splenectomy on peripheral lymphocytes and their subsets in patients with hypersplenism associated with cirrhotic portal hypertension.肝硬化门静脉高压症相关脾功能亢进患者全脾切除对周围淋巴细胞及其亚群的影响。
Sci Rep. 2021 Oct 28;11(1):21246. doi: 10.1038/s41598-021-00692-x.
2
Immunoglobulin for Treating Bacterial Infections: One More Mechanism of Action.用于治疗细菌感染的免疫球蛋白:又一种作用机制。
Antibodies (Basel). 2019 Nov 3;8(4):52. doi: 10.3390/antib8040052.
3
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
中国多中心研究:肝癌切除术后晚期复发的危险因素、模式和结局。
JAMA Surg. 2019 Mar 1;154(3):209-217. doi: 10.1001/jamasurg.2018.4334.
4
Hepatitis B virus inhibits the expression of complement C3 and C4, and .乙型肝炎病毒抑制补体C3和C4的表达,以及…… (原文此处不完整)
Oncol Lett. 2018 May;15(5):7459-7463. doi: 10.3892/ol.2018.8223. Epub 2018 Mar 9.
5
Antiviral Therapy Reduces Hepatocellular Carcinoma Recurrence in Patients With Low HBV-DNA Levels: A Randomized Controlled Trial.抗病毒治疗降低低 HBV-DNA 水平肝癌患者的复发率:一项随机对照试验。
Ann Surg. 2018 Dec;268(6):943-954. doi: 10.1097/SLA.0000000000002727.
6
Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection.抗病毒治疗可改善 HBV 感染和肝内胆管细胞癌患者行肝切除术后的生存。
J Hepatol. 2018 Apr;68(4):655-662. doi: 10.1016/j.jhep.2017.11.015. Epub 2017 Nov 16.
7
Alternative splicing of hepatitis B virus: A novel virus/host interaction altering liver immunity.乙型肝炎病毒的可变剪接:一种改变肝脏免疫的新型病毒/宿主相互作用。
J Hepatol. 2017 Oct;67(4):687-699. doi: 10.1016/j.jhep.2017.05.025. Epub 2017 Jun 7.
8
Causes of peripheral cytopenia in hepatitic cirrhosis and portal hypertensive splenomegaly.肝硬化和门静脉高压性脾肿大导致外周血细胞减少的原因。
Exp Biol Med (Maywood). 2017 Apr;242(7):744-749. doi: 10.1177/1535370217693113. Epub 2017 Jan 1.
9
Serum Immunoglobulin A (IgA) Level Is a Potential Biomarker Indicating Cirrhosis during Chronic Hepatitis B Infection.血清免疫球蛋白A(IgA)水平是慢性乙型肝炎感染期间提示肝硬化的潜在生物标志物。
Gastroenterol Res Pract. 2016;2016:2495073. doi: 10.1155/2016/2495073. Epub 2016 Mar 30.
10
Epidemiological survey of human cytomegalovirus antibody levels in children from Southeastern China.中国东南部儿童人巨细胞病毒抗体水平的流行病学调查。
Virol J. 2014 Jul 4;11:123. doi: 10.1186/1743-422X-11-123.